Literature DB >> 21246484

Fibular free flap with arteria peronea magna: the role of preoperative balloon occlusion.

Benjamin B Rahmel1, Thomas M Snow, Martin D Batstone.   

Abstract

The free fibular osteocutaneous flap is a commonly used donor for reconstruction of mandibular defects. Vascular abnormalities and leg trauma are relative contraindications to the use of a fibular free flap. Peroneal arteria magna (PAM) is one such vascular abnormality that may preclude the use of the graft due to the high risk of lower-limb ischemia. Lower-limb angiography is the standard for assessing the lower-limb vascular anatomy; however, the indications remain controversial. Although balloon occlusion has been used to assess the vascular supply in distal bypass surgery, there have no reported cases of balloon occlusion to assess the viability of the distal extremity with PAM. Intraoperative assessment of vascular anatomy with an aborted harvest can lead to significant morbidity and cost. Balloon occlusion provides a relatively safe and minimally invasive technique for assessment of potential lower-limb ischemia in patients with PAM. © Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2011        PMID: 21246484     DOI: 10.1055/s-0030-1270531

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  3 in total

1.  Four Lessons Learned from Complications in Head and Neck Microvascular Reconstructions and Prevention Strategies.

Authors:  Luís Vieira; Daniel Isacson; Eleonora O F Dimovska; Andres Rodriguez-Lorenzo
Journal:  Plast Reconstr Surg Glob Open       Date:  2021-01-22

2.  Free gracilis end-to-side microanastomosis to a peronea arteria magna: a case report.

Authors:  Dallan Dargan; Raghuram Lakshminarayan; Cher Bing Chuo
Journal:  J Med Case Rep       Date:  2021-12-13

Review 3.  Complication of osteo reconstruction by utilizing free vascularized fibular bone graft.

Authors:  Qifeng Ou; Panfeng Wu; Zhengbing Zhou; Ding Pan; Ju-Yu Tang
Journal:  BMC Surg       Date:  2020-10-02       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.